Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty.

Marta BanaszkiewiczArkadiusz PietrasikMichał FlorczykPiotr KędzierskiMichał PiłkaRafał MańczakJanusz KochmanGrzegorz Opolski Adam Torbicki Marcin Kurzyna Szymona Darocha

Published in: Diagnostics (Basel, Switzerland) (2021)

sST2 concentration in patients with CTEPH treated with BPA changes significantly in the postprocedural period and is significantly higher in the group with complications in postprocedural period.

Keyphrases

pulmonary hypertension
pulmonary artery
risk factors
pulmonary arterial hypertension
newly diagnosed